FIELD: medicine; stomatology.
SUBSTANCE: invention can be used for treatment of maxillofacial inflammatory diseases. For this purpose after suppurative focus is surgically opened and drained, intratissular subcutaneous or submucous introduction of Perftoran follows. Thus Perftoran is injected from four injection points equally-interspaced by perimeter, in amount 0.3-0.5 ml and more per one point, depending on wound area. Course of treatment is 4-6 days.
EFFECT: improved efficiency of anti-inflammatory therapy due to uniform distributed Perftoran emulsion directly within inflammation centre.
5 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING PURULENT WOUNDS IN MAXILLOFACIAL REGION | 1999 |
|
RU2159086C1 |
METHOD FOR TREATING ODONTOGENIC PHLEGMONS OF ORAL AREA | 2003 |
|
RU2244518C2 |
METHOD FOR INTEGRATED TREATMENT OF MAXILLOFACIAL ABSCESSES AND PHLEGMONS IN CHILDREN BY OINTMENT WITH FURACILIN, LIDOCAINE AND DIBUNOL | 2011 |
|
RU2470629C1 |
METHOD FOR INTEGRATED TREATMENT OF MAXILLOFACIAL ABSCESSES AND PHLEGMONS IN CHILDREN BY OINTMENT WITH FURACILIN, LIDOCAINE AND DIBUNOL | 2011 |
|
RU2445075C1 |
METHOD FOR TREATING ABSCESSES, SOFT TISSUE PHLEGMONS | 2006 |
|
RU2284825C1 |
INFECTED INJURY HEALING DRESSING | 1999 |
|
RU2171693C1 |
METHOD FOR COMPLEX THERAPY OF AVERAGE-DEGREE ORAL PHLEGMONS | 2007 |
|
RU2320329C1 |
METHOD OF MAXILLOFACIAL PHLEGMONS TREATMENT | 2007 |
|
RU2328292C1 |
METHOD FOR EVALUATING ACUTE ODONTOGENIC INFLAMMATION FOCUS STATE | 1997 |
|
RU2132068C1 |
METHOD FOR TREATING PATIENTS WITH MANDIBULAR FRACTURES | 2006 |
|
RU2301674C1 |
Authors
Dates
2008-08-10—Published
2006-12-12—Filed